Newsom-Davis J - Search Results

1

Thymic myoid cells and germinal center formation in myasthenia gravis; possible roles in pathogenesis.

Roxanis I, Micklem K, McConville J, Newsom-Davis J, Willcox N. Roxanis I, et al. J Neuroimmunol. 2002 Apr;125(1-2):185-97. doi: 10.1016/s0165-5728(02)00038-3. J Neuroimmunol. 2002. PMID: 11960656

2

The myasthenia gravis thymus: a rare source of human autoantibody-secreting plasma cells for testing potential therapeutics.

Hill ME, Shiono H, Newsom-Davis J, Willcox N. Hill ME, et al. Among authors: newsom davis j. J Neuroimmunol. 2008 Sep 15;201-202:50-6. doi: 10.1016/j.jneuroim.2008.06.027. Epub 2008 Aug 22. J Neuroimmunol. 2008. PMID: 18722675

3

Presentation of endogenous acetylcholine receptor epitope by an MHC class II-transfected human muscle cell line to a specific CD4+ T cell clone from a myasthenia gravis patient.

Baggi F, Nicolle M, Vincent A, Matsuo H, Willcox N, Newsom-Davis J. Baggi F, et al. J Neuroimmunol. 1993 Jul;46(1-2):57-65. doi: 10.1016/0165-5728(93)90233-o. J Neuroimmunol. 1993. PMID: 7689595

4

Antigen presentation by thymoma epithelial cells from myasthenia gravis patients to potentially pathogenic T cells.

Gilhus NE, Willcox N, Harcourt G, Nagvekar N, Beeson D, Vincent A, Newsom-Davis J. Gilhus NE, et al. J Neuroimmunol. 1995 Jan;56(1):65-76. doi: 10.1016/0165-5728(94)00134-a. J Neuroimmunol. 1995. PMID: 7822483

5

Diverse patterns of unresponsiveness in an acetylcholine receptor-specific T-cell clone from a myasthenia gravis patient after engaging the T-cell receptor with three different ligands.

Bond AP, Corlett L, Curnow SJ, Spack E, Willcox N, Newsom-Davis J. Bond AP, et al. J Neuroimmunol. 1998 Mar 1;82(2):182-90. doi: 10.1016/s0165-5728(97)00202-6. J Neuroimmunol. 1998. PMID: 9585815

6

T cell responses to D-penicillamine in drug-induced myasthenia gravis: recognition of modified DR1:peptide complexes.

Hill M, Moss P, Wordsworth P, Newsom-Davis J, Willcox N. Hill M, et al. J Neuroimmunol. 1999 Jun 1;97(1-2):146-53. doi: 10.1016/s0165-5728(99)00038-7. J Neuroimmunol. 1999. PMID: 10408968

7

Autoantibodies to IL-12 in myasthenia gravis patients with thymoma; effects on the IFN-gamma responses of healthy CD4+ T cells.

Zhang W, Liu JL, Meager A, Newsom-Davis J, Willcox N. Zhang W, et al. J Neuroimmunol. 2003 Jun;139(1-2):102-8. doi: 10.1016/s0165-5728(03)00136-x. J Neuroimmunol. 2003. PMID: 12799027

8

Antibodies in myasthenia gravis and related disorders.

Vincent A, McConville J, Farrugia ME, Bowen J, Plested P, Tang T, Evoli A, Matthews I, Sims G, Dalton P, Jacobson L, Polizzi A, Blaes F, Lang B, Beeson D, Willcox N, Newsom-Davis J, Hoch W. Vincent A, et al. Ann N Y Acad Sci. 2003 Sep;998:324-35. doi: 10.1196/annals.1254.036. Ann N Y Acad Sci. 2003. PMID: 14592891 Review.

9

Detection and characterization of MuSK antibodies in seronegative myasthenia gravis.

McConville J, Farrugia ME, Beeson D, Kishore U, Metcalfe R, Newsom-Davis J, Vincent A. McConville J, et al. Ann Neurol. 2004 Apr;55(4):580-4. doi: 10.1002/ana.20061. Ann Neurol. 2004. PMID: 15048899

10

Seronegative myasthenia gravis.

Vincent A, McConville J, Farrugia ME, Newsom-Davis J. Vincent A, et al. Semin Neurol. 2004 Mar;24(1):125-33. doi: 10.1055/s-2004-829589. Semin Neurol. 2004. PMID: 15229799 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

322 results

Search Page